$AI

SIEBEL THOMAS M sold $4.8M of AI

SIEBEL THOMAS M (CEO and Chairman of the Board) sold 453,314 shares of C3.ai, Inc. (AI) at $10.51 ($4.76M total) on 2026-08-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SIEBEL THOMAS M
Published Aug 13, 2026, 9:27 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 9:45 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AI
Neutral
medium confidence
Mentioned
$AI
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AINeutralLow
01

Why it matters

Traders may use the sale as a sentiment input, but the 10b5-1 pre-arranged plan reduces the likelihood of a strong directional fundamental signal.

02

Market read

Fresh insider-sale disclosure for AI, but with 10b5-1 framing, so expected impact is modest.

03

What to watch

The article provides no context on total insider holdings beyond post-transaction shares, no sale schedule details, and no concurrent company news, limiting inference.

Relevance 5/10Novelty 5/10Timing: today’s SEC Form 4 filing (filed 2026-08-13)

Background

The article is an SEC Form 4 insider transaction disclosure for C3.ai, Inc. (AI) by its CEO and Chairman, filed on 2026-08-13.

Company-level read

Ticker impact

$AINeutralMedium confidence
Context

C3.ai CEO and Chairman sold 453,314 shares in an open-market transaction totaling about $4.76M, per a new SEC Form 4 filed today.

Expected impact

Likely limited, short-lived sentiment impact; watch for follow-through only if additional filings or company-specific news accompany it.

Evidence & confidence

This is a Form 4 insider sale with a stated 10b5-1 pre-arranged plan, which typically reduces the signal strength versus discretionary selling.

Market effects

Minimal sector read-through; insider-sale filings rarely reset sector expectations without accompanying operational or guidance changes.

None indicated.

None indicated.

Counterpoint

A 10b5-1 plan can reflect routine liquidity needs rather than bearish expectations, so the market may overreact if it treats it as a discretionary sell.

Key entities

  • C3.ai, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • SIEBEL THOMAS M

    CEO and Chairman of the Board, reported an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIMed

Trump Family Pockets Half A Billion As Trump-Backed Crypto Firm Moves To Sell Only Revenue-Generating Business

The Wall Street Journal reports Nasdaq-listed AI Financial (formerly Alt5 Sigma) is in talks to sell its only revenue-generating payments subsidiary to Tokyo-based Perpetuals.com for up to $15 million. The unit generated about $25 million revenue in 2024. AI Financial’s losses followed World Liberty’s August 2025 WLFI token purchase and WLFI’s ~70% decline, with AI Financial reporting a $271 million quarterly loss.

$AIMedAI 9/10

C3.ai Q4 2026 Earnings Call Transcript - C3.ai (NYSE:AI)

C3.ai held its Q4 earnings call, reporting total revenue of $51.6 million, with subscription revenue 94% of the total. The company said it cut headcount about 35% and expects ~$135 million in annual operating cost savings. CEO Tom Siebel cited poor sales execution and plans to expand its target accounts. FY2027 guidance calls for $210–$240 million revenue and non-GAAP operating loss of $128–$160 million.

$AIHighAI 9/10

Live: Will C3.ai Beat Q4 Earnings After the Bell Tonight?

C3.ai (AI) reports Q4 fiscal 2026 results after the close. The company is focused on revenue within guidance ($48.0M–$52.0M), improving GAAP gross margin from 17% (down from 59% a year earlier), and expanding federal bookings, which rose 134% YoY to 55% of total bookings. Wall Street has 6 sell and 7 hold ratings; average target is $8.82 vs. $10.51.

$AIMedAI 8/10

Wall Street Has a Consensus on This AI Stock. The Consensus Is Dead Wrong.

The article argues that Wall Street’s consensus on C3.ai (AI) is inconsistent and may not reflect deteriorating fundamentals. It cites a hold consensus from 12 analysts with an average price target near $17 versus a stock price around $9.50. For fiscal Q1 2026 ended July 31, C3.ai reported about $50M revenue, missed guidance, posted a $0.40 loss per share vs $0.30 estimate, and guided continued pressure.

$AIMedAI 9/10

Thomas Siebel Is Back as C3.ai CEO. Will This Help the Stock Rebound?

C3.ai shares are down 59% over 12 months as the company’s sales have declined, despite having 100+ enterprise AI turnkey solutions. After CEO/founder Thomas Siebel stepped down in 2024 for health reasons and Stephen Ehikian took over Sept. 1, 2025, C3.ai reported preliminary Q4 revenue of $51.6M vs. $108.7M a year earlier. The company says Siebel returned as CEO May 8.